A one-on-one with Fabian Gerlinghaus, co-founder and CEO of Cellares, who discusses the quest to overcome bottlenecks in industrial scale cell therapy manufacturing
Nicholas Saraceno, Editor
Advertisement
Nicholas Saraceno is Editor of Pharmaceutical Commerce. He can be reached at [email protected].
Articles by Nicholas Saraceno, Editor
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novo Nordisk Rolls Out $199 Intro Offer for Wegovy and Ozempic, Months Ahead of Planned Price Cuts
2
Pharma Pulse: Patients Struggle to Identify Safe Online Pharmacies, as Novo Nordisk Launches Access Offers
3
How Modernizing the Supply Chain Lowers Costs and Expands Access to OTC Medicines
4
Pharma Pulse: Rural Vaccine Gaps, Semaglutide Organ-Protective Benefits, and Amazon Pharmacy’s Urgent Care Expansion Shape Healthcare Outlook
5
